Podcasts about treatment resistant depression

Summary: *Ron Jones discusses treatment resistant depression (TRD), which occurs when multiple classes of antidepressant medications fail to provide relief. *TRD is described as a subcategory of major depressive disorder, unrelated to therapy but linked to the ineffectiveness of psychotropic medications. *Ron shares his personal experience with TRD, highlighting the frustration and discouragement of ineffective treatments and the lengthy process of testing medications. *He suggests that emotional and mental needs, when unmet, can lead to chemical imbalances, and treating only the symptoms without addressing underlying issues is insufficient. *Jones emphasizes the importance of understanding one's identity in relation to God, suggesting that misalignment can contribute to mental health issues. *He recounts a pivotal moment in a church service where he felt the Holy Spirit's guidance, leading to a significant change in his depression. *Jones discusses the role of community, vulnerability, and addressing lies or misconceptions about oneself as crucial steps in the healing process. *He advocates for the recognition of negative emotions as truthful indicators and encourages seeking the Holy Spirit's guidance for healing. *Jones stresses the importance of relational accountability and having supportive people in one's life to provide honest feedback. *He concludes by affirming the possibility of finding hope and new life even after experiencing deep depression, through a relationship with Christ and understanding one's true identity. PODCAST INTRO: My guest today, Ron Jones, is a pastoral counselor and mental health advocate and he stopped by to share his first-hand experiences and insights into his victory over treatment-resistant depression (TRD). This discussion touches on the complexities of living with TRD, the challenges of traditional treatment methods, and the importance of having a strong identity in Christ and growing in faith throughout the healing process. What is Treatment-Resistant Depression? Treatment-resistant depression is a severe form of major depressive disorder. Ron explained that clinically, it is defined as depression that does not respond to at least three different classes of antidepressant medications. Ron also shared that this condition is not merely about resistance to therapy but is specifically linked to the ineffectiveness of psychotropic medicines. The Struggle with Traditional Treatments Ron describes the frustration of navigating the medical system, which often prioritizes treating symptoms over addressing root causes. He likens the process to taking aspirin for a headache without investigating the underlying cause. He even pointed out that this approach can be disheartening, especially when medications take weeks to show results, if at all. A Journey of Identity and Faith Throughout his journey, Ron emphasizes the importance of understanding one's true identity. He believes that much of mental illness stems from a misalignment between who we are and who we perceive ourselves to be. For Ron, this journey of self-discovery was deeply intertwined with his faith, which provided a foundation and a source of hope. This foundation withstood 13 years of struggling AND also provided room for growth and intimacy with Christ as he searched how to get out from under his depression. As shared in then opening clip….Ron was desperately clinging to hope God and yet had no hope. Steps Toward Healing Ron offered practical steps for those struggling with depression: Evaluate Your "Have To's": Examine the non-negotiables in your life that might be contributing to your stress and consider whether they are truly necessary. Identify Primary Lies: Reflect on the negative emotions you feel most often and ask the Holy Spirit to reveal the first time you felt this way. Listen for the Holy Spirit: Spend time in silence, asking the Holy Spirit, "What's We most important thing I could hear right now?" and be open to whatever answer comes without editing it. Something I added, only because I have to do this: when I'm seeking God for an answer I have learned that I need to write it down. It is very commen for me to forget the details of what He spoke into my spirit. If you want to add a #4: Write down what you hear the Holy Spirit speak into your spirit and refer to it as often as you need to. Conclusion Ron's story gives us a deeper revelation about Treatment Resistant Depression because it's from his personal experience; his 13 year battle to find relief. His faith, community, and self-reflection was instrumental in overcoming his TRD. While traditional treatments may fall short mainly because they're go to is to fix things with medicine vs looking at a more holistic approach that would include a deep dive into one's identity. So Ron's journey offers hope and encouragement to those facing similar struggles, reminding us that there is always a path to discovering the benefits of knowing the truth and having a stronger identity. Live Loved and Thrive! @alifeofthrive.com Sherrie Pilk With regard to the acronyms you'll hear Ron use, here is what they stand for (this info is more current than the audio intro to this podcast episode): SSRIs - (Selective Serotonin Reuptake Inhibitors) are a class of antidepressants that help treat depression Sozo is a practice/method used by some Christian ministries to describe their approach to inner healing, which focuses on restoring broken relationships with God and healing past trauma (for more info check out sozo.org)  SNRIs - Serotonin-Norepinephrine Reuptake Inhibitors PCP - Primary Care Physician BPD - Borderline Personality Disorder Resources along the same topic: Unrelenting Pain Known as The Suicide Disease (CRPS), with Darci Steiner -  https://alifeofthrive.com/wp-admin/post.php?post=9563&action=edit Autoimmune Disease, Pulmonary Fibrosis and Faith, with Sara Salazar - https://alifeofthrive.com/2021/09/01/autoimmune-disease/ Hope in the Midst of Chronic Illness, with Sara Willoughby - https://alifeofthrive.com/2025/01/01/hope-in-the-midst-of-chronic-illness-with-sara-willoughby/ Connect with Ron: Ron's podcast w/his friend (Nick): https://podcasts.apple.com/us/podcast/ron-and-nicks-best-friend-podcast/id1599899345 Amazon link to Ron's most recent book - The Little Book of Forgiveness - The Pathway to Freedom: https://www.amazon.com/Little-Book-Forgiveness-pathway-freedom/dp/B0DYNXWKBW/ref=tmm_pap_swatch_0?_encoding=UTF8&dib_tag=se&dib=eyJ2IjoiMSJ9.oljVyfzmkcvd-tRRqhc8qzcDCCeB-vKQpdasKmcPpGyLFkFehAMYradfiTGZARL3MVN6ar_YRewiXpEMrwt-ig.0u01g9j57uS-UD4NfXgrNw4IxQKkAQYxAoW0rJG8AV0&qid=1743803194&sr=8-1 Ron's Bio: R. Kenward Jones is a disruptive teacher, writer, podcaster (who isn't these days?), counselor, husband, father and grandfather.  He holds a bachelor's degree in mechanical engineering and master's degrees in biblical studies and counseling.  His debut novel, Buried at Sea, was published by Penmore Press in 2022.  Daily, he writes proverbs, parables and prayers and shares them on his Facebook page and website to inspire and encourage. R. Kenward Jones is a US Navy veteran and served as both an enlisted man and officer for 12 years before he left the military to become a pastor.  After a 13-year long bout with treatment resistant depression he left the ministry to reset his life.  He knows the Valley of the Shadow of Death and the power of personal Creativity as the way through it and out of it. Currently he works as a counselor and teaches the 515A “zero excuses” bootcamp at the local YMCA.  He and Tina, his high school sweetheart, have been married for 40 years, have two children and one grandchild, and live in Southeastern Virginia although they still consider the Shenandoah Valley to be their “home.”  R. Kenward Jones enjoys life and joy tempered by suffering and more than anything wants to help other sufferers experience the same.

Dr. Martijn Figee, director of the Mount Sinai Interventional Psychiatry Program, joins Heart of The East End Gianna Volpe on WLIW-FM amidst Mental Health Awareness Month to discuss the TRANSCEND clinical trial, which uses implants to help people living with Treatment-Resistant Depression. TRD is a condition diagnosed in people with a major depressive disorder (MDD) who have not responded to multiple treatments. Upwards of 730,000 (11%) of adults living in New York City have been diagnosed with MDD, according to a study published in 2024 by the city.Listen to the playlist on Apple Music

Draulio Araujo, professor at the Brain Institute in the University of Rio Grande Norte in Natal, Brazil, has been studying ayahuasca for more than 20 years. It's a psychedelic plant used in rituals in South America that has also been researched for its potential to treat depression. The effects of ayahuasca can last for hours and also lead to side effects including vomiting and diarrhea. The active psychedelic drug in ayahuasca is DMT, and so Dr. Araujo and his colleagues decided to conduct the first test of DMT itself, which is also an endogenous chemical and has been demonstrated to be safe. Hosted on Acast. See acast.com/privacy for more information.

Lead the way in depression management! We're joined by Dr. Jessi Gold, a psychiatrist and mental health advocate, who provides essential pearls on ways to recognize the multifaceted nature of depression and similarly presenting medical conditions. We also discuss the complexities of treatment options including various medication options and therapies, and how to choose between these treatments. Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Intro Case 1 from Kashlak Medical conditions that can mimic depression Diagnosis of depression How to explain depression to family Initial treatment options for depression Case 2 from Kashlak Suicide risk assessment Trialing, augmenting, and tapering of medications Pharmacogenetic testing Alternate treatment options: TMS, ECT, ketamine, psilocybin, cannabis Outro Credits Written and Produced by: Zoya Surani Show Notes, Infographic, and Cover Art: Zoya Surani Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Sai Achi MD,MBA,FACP Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Jessi Gold, MD Disclosures Dr. Gold reports no relevant financial disclosures. The Curbsiders report no relevant financial disclosures.  Sponsor: Panacea Financial  Visit PanaceaFinancial.com to explore financial solutions designed to make your life better. Sponsor: FIGS Go to WearFIGS.com and use the code FIGS-R-X to get 15% off your first order. Sponsor: Ezresus Listeners of the Cribsiders get access to a 2-month free trial, letting them use 100% of the features of the app. For more information visit www.ezresus.com/curbsiders Sponsor: Freed Visit Freed.ai and use code CURB50 to get $50 off your first month when you subscribe!

In this episode, our speakers discuss the use of psychedelic-assisted psychotherapy in the treatment for conditions such as depression and PTSD. This podcast is intended for individuals considering whether this approach could be helpful in treating their diagnosed psychiatric conditions. The conversation covers the role of psychotherapy in these treatments, the importance of ongoing research and the potential risks and contraindications involved. The discussion also explores how psychedelic agents uniquely impact brain function, contrasting this with standard treatments. Prof Mal Hopwood is the Ramsay Health Care Professor of Psychiatry at the University of Melbourne and the Director of the Professorial Psychiatry Unit at the Ramsay Clinic Albert Road (RCAR). A former President of the RANZCP, he is a dedicated researcher and clinician specialising in mood disorders and PTSD. He leads an active clinical trials group at RCAR, including in the area of psychedelic treatment.Dr Nigel Strauss has been a psychiatrist for 45 years and is currently a consultant at St Vincent's Hospital in Melbourne, as well as a psychedelic researcher at Swinburne University. He is a trained psychedelic psychotherapist and has written extensively on psychedelic medicine and psychology. He is currently sponsoring a trial on MDMA-assisted psychotherapy at Monash University.Dr Diana Korevaar is a psychiatrist with experience in private practice, where she integrates trauma-based methods with routine psychiatric care. Over the past five years, she has been actively involved in psychedelic-assisted therapy research trials across a wide variety of psychiatric conditions.Prof Colleen Loo is a psychiatrist, Australian National Health and Medical Research Council Leadership Fellow, and Professor of Psychiatry at the University of New South Wales and the Black Dog Institute in Sydney. She is a clinical and research expert in electroconvulsive therapy, transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS) and ketamine. She is now also researching psychedelic-assisted therapy.Prof David Castle; Department of Psychiatry, The University of Tasmania; and Co-Director, Tasmanian Centre for Mental Health Service Innovation. He has wide clinical and research interests and has published widely. He has a current particular interest in psychedelic assisted therapy.References and Resources:Professor Richard J Davidson on the neuroplasticity of emotional wellbeingWhite Paper on the science of awe, which describes the impact of training in competencies which overlap with psychedelic mystical experienceCompassion Focused therapy in psychedelic assisted thTopic suggestion:If you have a topic suggestion or would like to participate in a future episode of Psych Matters, we'd love to hear from you.Please contact us by email at: psychmatters.feedback@ranzcp.orgDisclaimer:This podcast is provided to you for information purposes only and to provide a broad public understanding of various mental health topics. The podcast may represent the views of the author and not necessarily the views of The Royal Australian and New Zealand College of Psychiatrists ('RANZCP'). The podcast is not to be relied upon as medical advice, or as a substitute for medical advice, does not establish a doctor-patient relationship and should not be a substitute for individual clinical judgement. By accessing The RANZCP's podcasts you also agree to the full terms and conditions of the RANZCP's Website. Expert mental health information and finding a psychiatrist in Australia or New Zealand is available on the RANZCP's Your Health In Mind Website.

On today's special guest episode, we'll be exploring the topic of nitrous oxide with Dr. Charles Conway and Dr. Vasilis Hristidis.https://medicine.washu.edu/news/laughing-gas-relieves-symptoms-in-people-with-treatment-resistant-depression/https://pmc.ncbi.nlm.nih.gov/articles/PMC5825282/https://pubmed.ncbi.nlm.nih.gov/34108247/https://pubmed.ncbi.nlm.nih.gov/25577164/

Nick finishes his interview with Ron about his 13 year long battle with treatment resistant depression.

Thank you Alex Kimberling III, for developing this podcast topic! Thank you Kasey Doney OMS MS III for being great sidekick!This podcast provides some high yield information about Benzos and Barbiturates that start of the podcast. The remainder is about an emerging treatment for Treatment Resistant Depression--Propofol! Thank you to the physicians that blazed the podcast pathway over half a decade ago. Thank you to the new students that carry the torch! Thank you to the immortal Jordan Turner for creating the perfect bumper music! Most of all, thank you to everybody that listens in and learns with us.

Nick continues his interview with Ron about his 13 year long battle with treatment resistant depression and his recovery.

Nick interviews Ron about his 13 year long battle with treatment resistant depression and his recovery.

Shownotes   Exactly what Internal Family Systems therapy is The actual mechanism that creates the most profound level of healing Psychedelics as a loving catalyst to know ourselves more The truth about psychedelic stigma Why it's important to prepare your set and setting with psychedelics The difference between doses of psilocybin   Bio   Nick Brüss, EdD, LMFT, is a leading licensed psychedelic therapist, researcher and educator who is passionate about inspiring and helping people heal, grow and live creative lives. He's pioneering treatments and programs that harness the synergistic power of combining psychedelic medicine with cutting edge therapy and coaching.    Dr. Brüss was a clinical researcher and supervisor on the ground breaking FDA Phase III clinical trial of MDMA-assisted therapy for PTSD sponsored by MAPS, and is currently a lead therapist on the Phase III Psilocybin therapy study for Treatment Resistant Depression sponsored by Compass Pathways.    In private practice, he specializes in concierge ketamine-assisted and Internal Family Systems (IFS) therapy. He trains nationally and speaks internationally on psychedelic-assisted therapy safety and efficacy, and is a co-founder of the Psychedelic Coalition for Health, a psychedelic medicine education and training platform.    Dr. Brüss is also a Certified Mindfulness Facilitator through UCLA's Mindful Awareness Research Center at the Semel Institute for Neuroscience and Human Behavior, and a certified teacher of both Mindful Self-Compassion, and the Compassion Cultivation Training through the Center for Compassion, Altruism Research and Education at Stanford University School of Medicine.   Find more about Dr. Brüss' work at www.apracticeoffreedom.com and connect with him on LinkedIn and Instagram. Timestamps   00:01:14 - Guest introduction 00:02:20 - How Layla and Dr. Brüss originally connected 00:04:51 - Sign up for Layla's newsletter at LaylaMartin.com 00:06:51 - The first time Layla experienced her own somatic avoidance 00:11:14 - Humans are so beautiful when they don't have so much pain 00:13:52 - Dr. Brüss explains what Internal Family Systems therapy is 00:19:24 - Unlock your deepest passion inside The Tantric Mastermind for Couples 00:20:06 - Discover your most masculine confidence and presence with Men's Sexual Mastery 00:21:12 - Dr. Brüss introduces listeners to MAPS 00:24:36 - The actual mechanism that creates this profound level of healing 00:27:19 - Layla shares about her experiences with MDMA 00:30:43 - How IFS integrates with felt-sense experience 00:32:30 - How intellectually “getting” something isn't the same as being “in” it 00:36:33 - We don't realize how much power we actually have 00:38:44 - Discover MOOD™ Sex Magic 00:42:48 - How psychedelics can be a loving catalyst to know ourselves more 00:44:28 - Layla shares her experience with psychedelics 00:47:22 - Dr. Brüss and Layla drink MOOD Sex Magic 00:55:28 - Psychedelic stigma was intentionally created 00:57:02 - The war on disconnection 00:57:27 - Enhance your sensitivity and pleasure inside Crystal Pleasure 00:59:15 - Why it's important to prepare your set and setting with psychedelics 01:04:33 - Dr. Brüss shares about his first psychedelic experience 01:07:24 - The difference between doses of psilocybin 01:12:06 - How different psychedelics work on different situations 01:19:53 - Conclusion  

Intensive treatments for Treatment Resistant Depression, Anxiety or PTSD When you've tried two or three or six treatments for your depression, anxiety, or PTSD and nothing helps, you might feel even more hopeless, like a fulfilling life is not possible for you. But I have good news for you. There are literally 500–five hundred treatments for depression. We're talking treatments for severe forms of depression, anxiety, and PTSD. And most of them are surprisingly effective. So let's explore 9 interventions that science has shown to improve treatment resistant mental health conditions–and at the end I'll share what hasn't been proven to work. Some of these might be considered last-ditch efforts to treat treatment-resistant mental health conditions, but if you've been there, you know how desperate you feel and why it might be worth talking with your psychiatrist about these. Looking for affordable online counseling? My sponsor, BetterHelp, connects you to a licensed professional from the comfort of your own home. Try it now for 10% off your first month: https://betterhelp.com/therapyinanutshell Learn more in one of my in-depth mental health courses: https://courses.therapyinanutshell.com Support my mission on Patreon: https://www.patreon.com/therapyinanutshell Sign up for my newsletter: https://www.therapyinanutshell.com Check out my favorite self-help books: https://kit.co/TherapyinaNutshell/best-self-help-books  Therapy in a Nutshell and the information provided by Emma McAdam are solely intended for informational and entertainment purposes and are not a substitute for advice, diagnosis, or treatment regarding medical or mental health conditions. Although Emma McAdam is a licensed marriage and family therapist, the views expressed on this site or any related content should not be taken for medical or psychiatric advice. Always consult your physician before making any decisions related to your physical or mental health. In therapy I use a combination of Acceptance and Commitment Therapy, Systems Theory, positive psychology, and a bio-psycho-social approach to treating mental illness and other challenges we all face in life. The ideas from my videos are frequently adapted from multiple sources. Many of them come from Acceptance and Commitment Therapy, especially the work of Steven Hayes, Jason Luoma, and Russ Harris. The sections on stress and the mind-body connection derive from the work of Stephen Porges (the Polyvagal theory), Peter Levine (Somatic Experiencing) Francine Shapiro (EMDR), and Bessel Van Der Kolk. I also rely heavily on the work of the Arbinger Institute for my overall understanding of our ability to choose our life's direction. And deeper than all of that, the Gospel of Jesus Christ orients my personal worldview and sense of security, peace, hope, and love https://www.churchofjesuschrist.org/comeuntochrist/believe If you are in crisis, please contact the National Suicide Prevention Hotline at https://suicidepreventionlifeline.org or 1-800-273-TALK (8255) or your local emergency services. Copyright Therapy in a Nutshell, LLC

Nick interviews Ron about his 13 year long battle with treatment resistant depression and his recovery.

Thank you Ben Ballard, PMHNP-S for developing this podcast topic! This podcast addresses the use of Esketamine in treatment resistant depression. Thank you to the physicians that blazed the podcast pathway over half a decade ago. Thank you to the new students that carry the torch! Thank you to the immortal Jordan Turner for creating the perfect bumper music! Most of all, thank you to everybody that listens in and learns with us.

In this episode, Silvia Covelli, a former social science researcher at Harvard University, successful business woman, single mother, and now founder and CEO of The Healing Depression Project, talks about her recovery from 25 years of treatment resistant depression. During this time, she explored over 60 different treatment modalities which failed to provide lasting relief, until she hit on a formula that worked. Drawing on her vast personal experience of suffering in silence while trying to find solutions, and her eventual recovery, she put together a groundbreaking programme to offer sustainable relief to those suffering from treatment resistant depression called “The Healing Depression Project” with a fantastic team of functional medicine psychiatrists, including Dr. Kat Toups and Dr. Achina Stein.  Silvia reveals the surprisingly simple yet transformative practices that helped her overcome years of depression. She offers actionable insights into her programme's treatment plans and emphasises why identifying common biochemical root-causes of depression (such as toxins, poor gut health, hormone imbalance, and nutritional deficiencies) as well as making lifestyle changes (to include better sleep, diet, exercise, and meditation) are key to successful healing.    Silvia assures us that depression is not a life sentence and explains how those suffering from depression can sustainably heal. Now, her life mission is to share this programme and help others achieve sustainable and lifelong mental wellness. In this episode learn about:  Silvia's four simple pillars for successful healing; 1) exercise 2) meditation 3) nutrition 4) prioritising sleep.   Why conventional treatments, including psychiatry and medications, not only failed to address Silvia's symptoms (such as fatigue, poor cognition, anxiety, lack of connection, apathy, etc), but worsened them and created new ones.   Why you don't have to accept medication for life – and where to find support as you de-prescribe.   How and why depression isn't “just in your head” but has roots in biochemical imbalances.   Why mental trauma should be viewed in the same way as physical trauma.    The science of habit and how to embed lifestyle changes into daily life.   Why talk therapies, life coaching, somatic work, psychodrama and yoga are integral to finding Peace and Purpose.   What The Healing Depression Project is, how it's underpinned by functional medicine psychiatry and how to apply for it.

Dr. Mitch Shulman joined Ken Connors with his two minute checkup.

In this episode of the No Shame On U podcast, we sit down with Bryna Siegel Finer, Professor of English, as she shares her powerful story of resilience in the face of treatment-resistant depression. Bryna opens up about the challenges she faced, the treatments that fell short, and how transcranial magnetic stimulation (TMS) has helped her in her recovery. Join us for an inspiring conversation about finding hope, exploring innovative treatments, and reclaiming mental well-being, even when the journey feels darkest. The contents of the No Shame On U Podcast are for informational purposes only and are not a substitute for professional advice, diagnosis, or treatment. Always seek the advice of a mental health professional or other qualified health professional with any questions regarding your condition. If you are experiencing a mental health crisis or having suicidal thoughts, text or dial 988, the Suicide and Crisis Lifeline.

When traditional treatments for depression fail, where do we turn? It's easy to feel hopeless when depression impacts your life, or the life of someone you love. Fear not. This is the episode for you.In this episode of Sick Health with Kevin Ban, MD, we dive deep into one of the most promising frontiers in mental health treatment. Joined by Dr. Ben Yudkoff, Chief Medical Officer at Lumen Health and Medical Director of Interventional Psychiatry at Brigham and Women's Faulkner Hospital, we explore the fascinating world of ketamine therapy.Known primarily as an anesthetic, ketamine is emerging as a groundbreaking treatment for depression - but how does it work, are there risks, who is it really for, and what exactly is the difference between it and esketamine? From the molecular level to real patient experiences, we unpack the science and stories behind this transformative therapy.Starting with the basics, Dr. Yudkoff guides us through the remarkable journey of how ketamine went from the operating room to mental health breakthrough. We explore the intricate brain chemistry that makes this treatment unique, and how it helps create new neural pathways for those stuck in persistent negative thought patterns.We then tackle the practical aspects - from treatment protocols to insurance coverage, and the critical importance of proper clinical settings. Finally, we address the elephant in the room: the fears and misconceptions about "bad trips" and what really happens during treatment.There's no need to be misinformed anymore. After this episode, you'll understand:Three NON-CHEMICAL treatments for depression you can considerHow ketamine offers new hope for treatment-resistant depressionThe fascinating way ketamine helps rewire negative thought patternsWhy controlled clinical settings are crucial for safe and effective treatmentNavigate insurance coverage and access to ketamine therapyUnderstanding what to expect from treatment and maintenance plansOur conversation isn't just about medication - it's about hope, science, and the future of mental health treatment. Whether you're struggling with depression, know someone who is, or are simply curious about breakthrough treatments in psychiatry, this episode offers valuable perspective on one of today's most promising therapeutic options.As Dr. Yudkoff shares, "As a provider who has lookedFollow us on YouTube and leave your comments at: https://www.youtube.com/@SickHealthwithKevinBanMD Connect with Kevin on Facebook: https://www.facebook.com/profile.php?id=61558197731269 Instagram: https://www.instagram.com/sickhealthigsh=MXQ5Y3Q1ZjE0bnZmdQ%3D%3D Threads: https://www.threads.net/@sickhealth Linkedin: https://www.linkedin.com/company/sick-health-with-kevin-ban-md/ Tik Tok: https://shorturl.at/oORXY Contact email: team@sickhealthshow.com Executive Producer: Kevin Ban, MD Production Director, Editor and Producer: Bat-Sheva Guez Graphic designer: Leah VanWhy YouTube SEO: Lighthouse-Digitalmarketing.com Social media: Rebekah Pajak Intern: Nicole Berritto This show's content represents the personal opinions of Kevin Ban, MD. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment, and does not create a physician-patient relationship with Kevin Ban, MD. Always seek the advice of your physician or other health car...

Download my free guided meditation audio bundle here: https://thewellnessengineer.com/audiobundle     Have you heard there's new hope for overcoming depression, even for those with chronic or treatment-resistant symptoms? Join me and my guests, Silvia Covelli & Dr. Achina Stein, DO, DFAPA, FACN, ABIHM, IFMCP, to learn more about a new, innovative, research-backed method that focuses on uncovering the root causes of depression, offering fresh alternatives when traditional treatments fall short, helping you reclaim your life.   In this episode you'll learn: ⏰ 01:00 - Intro ⏰ 06:27 - Silvia's journey through 25 years of chronic depression ⏰ 12:26 - The many puzzle pieces of depression  ⏰ 17:08 - Holistic approaches to healing depression  ⏰ 25:49 - The 45-day in-person Healing Depression Project program ⏰ 36:15 - The ONE thing you can do to activate self-healing  Check out Silvia Covelli's & Dr. Achina Stein's Bio: Dr. Achina Stein DO, DFAPA, FACN, ABIHM, IFMCP Dr. Stein is the Clinical Director at the Healing Depression Project. She is a leading expert in Functional Medicine Psychiatry and a best-selling author with 30 years of experience helping people recover from depression. She is a board-certified psychiatrist, a Distinguished Fellow of the American Psychiatric Association, a certified practitioner of the Institute for Functional Medicine, and a former Clinical Assistant Professor of Psychiatry and Human Behavior at The Warren Alpert Medical School of Brown University. Dr. Stein's Amazon international bestselling book, “What If It's NOT Depression? Your Guide to Finding Answers,” offers groundbreaking functional medicine perspectives, instilling hope and providing healing pathways for those facing chronic depression. In the 45-Day Depression Recovery Program offered by the Healing Depression Project, Dr. Stein works on identifying and addressing all the root causes of your depression-like symptoms. This program brings hope to those who have long struggled with depression and have not found relief with other treatments, including antidepressant medications.   Silvia Covelli Silvia is the founder of the Healing Depression Project. She is an honors graduate from Boston College and a former social science researcher at Harvard University. She pursued graduate studies in finance and business law, and dedicated her career to entrepreneurship, becoming a skilled businesswoman. In parallel with her thriving career, Silvia faced relentless and chronic depression, exploring over 60 different treatments without finding sustained relief. Her personal struggle, combined with her extensive background in human transformation and mind-body connection, led her to develop a program that remarkably eradicated 25 years of depression symptoms, leaving her depression-free ever since. This breakthrough later inspired the creation of the Healing Depression Project, and helping others break free from depression became her life mission.   Silvia Covelli's & Dr. Achina Stein's gift and link: Why Am I Still Depressed? Top 4 Mistakes You're Making - Free E-Guide. A Practical Starter Guide to Overcome Chronic and Treatment-Resistant Depression: https://go.healingdepressionproject.com/guide  Connect with Silvia Covelli & Dr. Achina Stein: Website: https://www.healingdepressionproject.com/  ***** Hi there! I am Jane Hogan, the Wellness Engineer, and the host of Wellness By Design. I spent 30 years designing foundations for buildings until the pain and inflammation of rheumatoid arthritis led me to hang up my hard hat and follow my heart. Now I blend my backgrounds in science and spirituality to teach people how to tap into the power of their mind, body and soul. I help them release pain naturally so they can become the best version of themselves.    Wellness By Design is a show dedicated to helping people achieve wellness not by reacting to the world around them but by intentionally designing a life based on what their own body needs. In this show we explore practices, methods and science that contribute to releasing pain and inflammation naturally.   Learn more at https://thewellnessengineer.com   Would you like to learn how to release pain by creating more peace and calm?  Download my free guided meditation audio bundle here: https://thewellnessengineer.com/audiobundle   Connect with Jane:  Facebook: https://www.facebook.com/JaneHoganHealth/ Instagram: https://www.instagram.com/janehoganhealth    

https://renegadehealthboss.com In episode 130 Heather Gray FDN-P welcomes Silvia Covelli , who opens up about her long struggle with chronic depression and the misconceptions surrounding mental health. Silvia Covelli shares her journey and insights on effective treatment methodologies that combine functional medicine, metabolic psychiatry, and lifestyle transformation. They discuss the vital connection between physical and mental health and challenge the traditional psychiatric model In this podcast you will discover 00:00 Introduction to the podcast and the mission to explore advanced health and wellness topics. 02:31 Silvia joins the conversation, sharing her passion for addressing depression openly and honestly. 03:16 Silvia discusses her background and her personal battle with chronic depression for over 25 years. 05:38 The stigma around depression and the pressure to feel grateful despite personal struggles. 07:45 Discussion about the lack of holistic approaches in traditional psychiatry and the need for comprehensive physical health evaluations. 09:20Silvia's realization that conventional methods weren't working for her and her determination to seek alternative solutions. 10:51 Critique of the psychiatric model that often neglects the connection between mind and body. 12:18 Discussion about the long-term effects of medication on youth and the lack of holistic support in treatment. 14:09 A preview of what's to come in the next segment, focusing on Silvia's Healing Depression project. 17:18 Silvia discusses her experiences with gaslighting and the lack of effective treatment for her depression, emphasizing the need for comprehensive care. 18:51 Introduction to the Healing Depression Project, which blends functional medicine and metabolic psychiatry 20:25 The importance of dietary changes and how food impacts mental health, highlighting the role of nutrition in treating depression. 22:24 Silvia explains the 45-day program structure, including a 30-day retreat focused on medical assessments and lifestyle training. 28:41 Information on scholarships available for participants in the 2025 program, promoting inclusivity and accessibility. To Get BioMed: Contact Dr. Drobot here https://thebiomedcenter.com/ Tel:480-614-5820 Only contact the Scottsdale location To get CAROL Bike Click here https://carolbike.com/ use code RHB to get $100 off the CAROL Bike offers a 100-day return policy. A full refund, buy with confidence. If you are a practitioner please open an account with MHP here www.mhpvitamins.com Guest Bio: Silvia, the founder and CEO of the Healing Depression Project, is an honors graduate from Boston College and a former social science researcher at Harvard University. While building her successful entrepreneurial career, she battled chronic depression and underwent over 60 treatments without lasting relief. This personal struggle, combined with her expertise in human transformation and mind-body connection, led her to develop a program that eliminated 25 years of depression symptoms, inspiring her mission to help others achieve freedom from depression through the Healing Depression Project. Website: www.HealingDepressionProject.com Free E-Guide for the audience www.HealingDepressionProject.com/Gift Foundations of Health and Healing [Guide] Discover the transformative journey to better health with This comprehensive guide by Heather Gray delves into the core principles of holistic wellness, offering actionable strategies to reclaim your vitality. From nutrition and stress management to restorative practices, this ebook is your essential companion for a balanced and vibrant life. Perfect for anyone looking to make lasting changes to their health and well-being, this guide empowers you with the knowledge and tools needed to take control of your health naturally. Start your healing journey today FREE mini eBook https://rhbcourses.com/discount/ACTION --- Support this podcast: https://podcasters.spotify.com/pod/show/renegadehealthboss/support

I'm happy to welcome back a previous guest on the podcast. Lynn Wilhite is a licensed clinical social worker who joined me for Episode 263, Coping with Treatment-Resistant Depression. Things have changed for Lynn since she has recently been diagnosed with autism, ADHD, and PTSD. She shares the impact of her diagnoses and how she's making connections about why things were so difficult for her in the past. Her insights help us understand how the many layers and factors of ADHD and autism have complicated her journey. Lynn has paused her work in therapy and social work to focus on her healing, understand her diagnoses, and learn more about her son's autism diagnosis. She feels passionate about bringing neurodivergence into the postpartum conversation, along with normalizing and destigmatizing autism and other forms of neurodivergence for new moms. She is currently writing a book about her postpartum and parenthood journey. Join us to learn more from Lynn's story! Show Highlights: Developments in Lynn's life since her last visit to Mom & Mind The prevalence of parents being diagnosed with autism alongside their children Lynn's diagnostic process—and how her struggles in life began to make sense Stereotypical autism vs. female autism A constant battle of “defending” a diagnosis Medical gaslighting that women have to endure for themselves and their children Autism's part in the challenges of pregnancy and postpartum, even in the smallest details Autism's effects in Lynn's life “Should I have even had a child?” Depression and anxiety are highly comorbid with autism. Masking skills are at their finest in autistic adults. Lynn's biggest lessons learned on her journey The value of support and community Resources: Connect with Lynn Wilhite: Instagram Lynn Wilhite's other Mom & Mind episode:  Episode 263 Call the National Maternal Mental Health Hotline at 1-833-TLC-MAMA or visit cdph.ca.gov Please find resources in English and Spanish at Postpartum Support International, or by phone/text at 1-800-944-4773. There are many free resources, like online support groups, peer mentors, a specialist provider directory, and perinatal mental health training for therapists, physicians, nurses, doulas, and anyone who wants to be more supportive in offering services.  You can also follow PSI on social media: Instagram, Facebook, and most other platforms Visit www.postpartum.net/professionals/certificate-trainings/ for information on the grief course.   Visit my website, www.wellmindperinatal.com, for more information, resources, and courses you can take today! If you are a California resident looking for a therapist in perinatal mental health, email me about openings for private pay clients!

We count down the top 10 research updates of the past year with a focus on treatment resistant depression and benzo withdrawal.CME: Take the CME Post-Test for this EpisodePublished On: 10/14/2024Duration: 19 minutes, 35 secondsChris Aiken and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

HOOK: Is it cruel or effective to use electroconvulsive therapy for treatment resistant depression? Disclaimer: all podcasts are educational and not a substitute for medical or professional advice. @03:53.31 What Is Treatment Resistant Depression@09:28.99 An Overview Of Electroconvulsive Therapy And How It Works@06:58.15 Pros And Cons and side effects Of ECTWant to build a healthy relationship with food?Book a FREE 1:1 eating evaluation call HEREBook a retreat call herehttps://stan.store/mindfoodsteph/mindfoodsteph_funnel_312254 Ask Stephhttps://forms.gle/uMBhmtLW16ancWEc8 To access more of my courses use this linkhttps://stan.store/mindfoodstephFREE Resources:Download my [FREE binge eating tracker tool]Experiencing burnout? Free guide here‌Psychological support:ADHD Assessment enquiry‌Website: http://www.mindfoodpsychology.com‌Social media:TikTokInstagramFacebookHelp lines ‌DISCLAIMER: This is NOT therapy or a substitute for psychological and medical advice.Review the podcast on Apple By sharing, following, or rating the podcast, you help me reach more people so they can understand the importance of mental health. Hosted on Acast. See acast.com/privacy for more information.

The University of Arkansas for Medical Sciences (UAMS) is the first medical facility in the United States to provide an innovative therapeutic treatment for major depressive disorder (MDD).The SAINT® neuromodulation system, developed by Magnus Medical, Inc., has been approved by the U.S. Food and Drug Administration to treat adults with depression who have not achieved improvement in their condition from the use of antidepressant medications. SAINT works by leveraging structural and functional magnetic resonance imaging (MRI) scans to inform a proprietary algorithm that pinpoints the optimal anatomical target for precise neurostimulation in individuals with major depression.The treatment is performed on an accelerated, five-day timeline, reducing the patient's treatment time from weeks to days. In previous clinical trials, treatment with SAINT for MDD resulted in a significant reduction in depressive symptoms at four weeks post-treatment following the five-day treatment protocol. Currently, SAINT can only be provided to patients who are being treated as inpatients.

CME credits: 1.00 Valid until: 15-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/diagnostic-hurdles-recognizing-and-addressing-treatment-resistant-depression/26462/ This series of bite-sized episodes contains important information on identifying and treating residual symptoms in major depressive disorder (MDD). Drs. Joseph Goldberg and Manpreet Kaur Singh discuss best practices for recognizing early symptoms, reaching a diagnosis, and treating residual symptoms in patients with MDD.

Welcome to another insightful episode of the NeuroNoodle Neurofeedback and Neuropsychology Podcast! This episode features tech legend Jay Gunkelman and special guest Dr. Robert Hedaya, a pioneer in Functional Medicine and laser therapy.

Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial  Nature Medicine The safety and tolerability of racemic ketamine may be improved if given orally, as an extended-release tablet (R-107), compared with other routes of administration. In this phase 2 multicenter clinical trial, male and female adult patients with treatment-resistant major depression (TRD) and Montgomery–Asberg Depression Rating Scale (MADRS) scores ≥20 received open-label R-107 tablets 120 mg per day for 5 days and were assessed on day 8 (enrichment phase). On day 8, responders (MADRS scores ≤12 and reduction ≥50%) were randomized to receive double-blind R-107 doses of 30, 60, 120, or 180 mg, or placebo, twice weekly for 12 weeks. Nonresponders on day 8 exited the study. Tolerability was excellent, with no changes in blood pressure, minimal reports of sedation, and minimal dissociation. The most common adverse events were headache, dizziness, and anxiety. R-107 tablets were effective, safe, and well tolerated in patients with TRD, enriched for initial response to R-107 tablets.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

Once considered a club drug, doctors are now using ketamine to treat depression, but there is no standard protocol.

WARNING: Age-Old Controversy Incoming... Is medication necessary in healing from depression, anxiety or other mental illnesses?One side says, "NO! How many people do you know that take medication and are still depressed?"The other side says, "YES, medication will help with the 'chemical imbalance' someone is facing in their brain chemistry."Who is right?I invited Dr. Paul Corona on The Be Better Broadcast to dive into what he calls "Mind & Body Healing."Dr. Paul is a proponent of using a specific cocktail of medication to help someone balance their brain chemistry and feel better.He has achieved great results with his clients and is the perfect example of someone who is FOR medication and actually gets results. In our conversation we will dive into:

老年人難治型憂鬱症（Treatment-Resistant Depression in Older Adults），有哪些臨床處理的重點？ 新英格蘭醫學期刊（NEJM）近期一篇回顧，特別以一位個案為實例，從第一線非精神科照顧者的角度，來介紹相關的治療與實證。幾項重點如下： 1. 什麼樣的程度可以說是「老年人難治型憂鬱症」（Treatment-Resistant Depression）？ 對兩種不同類型的抗憂鬱藥物，治療8週仍沒有改善 2. 實證對輕到中度「老年人難治型憂鬱症」的藥物治療原則？ - 低劑量第二代抗精神病藥：強烈的證據支持使用aripiprazole（起始每日劑量2.5mg，目標5-15mg），quetiapine是另一個如果病患願意在鎮靜的情況之下的選擇，但實證等級較低。 - 某些SSRI以及SNRI以外的抗憂鬱劑作為加強（augmentation），下列可以根據患者的症狀選擇： Bupropion：疲憊、體重增加、性功能受影響 Mirtazapine：失眠、焦慮、體重降低，但要注意跌倒風險會增加 3. 重度「老年人難治型憂鬱症」還可以考慮哪些有實證的方法治療？ - 經顱磁刺激（TMS）：系統性回顧顯示6.7%到54.3%得到緩解 - 電痙攣治療（ECT）：一項沒有對照組的觀察性研究，證實63%中度、75%重度患者得到緩解 - Esketamine鼻噴劑：目前隨機對照研究沒有證據能改善症狀 論文原文：Treatment-Resistant Depression in Older Adults. NEJM 2024;390:630-9. Powered by Firstory Hosting

Tachyphylaxis is a phenomenon described as the loss of response to a medication that was previously effective at an established dose. In a case report letter to the editors, Stefanie Cavalcanti, MD, Olga A. Lopez, MD, Simon Kung, MD, Jennifer L. Vande Voort, MD, Kristin Somers, MD, Mark A. Frye, MD, and Balwinder Singh, MD, MS, from the department of psychiatry and psychology at the Mayo Clinic, in Rochester, Minnesota, discuss “A Case of Tachyphylaxis After Long-Term Intravenous Racemic Ketamine for Treatment-Resistant Depression” in the May/June 2024 issue of the Journal of Clinical Psychopharmacology. In this podcast about the case report, two co-authors, Dr. Singh and Dr. Cavalcanti, discuss the compelling history of one 56-year-old woman with treatment-resistant recurrent major depressive disorder. Her depression, ongoing for 10 years, featured prominent symptoms of depressed mood, social isolation, low energy, decreased appetite, and anhedonia. Past medication trials included selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, tricyclic antidepressants, mood stabilizers, antipsychotics, benzodiazepines, and bitemporal electroconvulsive therapy with limited benefit. Ketamine, which is used increasingly for treatment-resistant depression (TRD), and other psychiatric disorders, was tried next. Sustained clinical response was observed for the first 2 years of intravenous ketamine treatment despite ongoing life stressors. In the following years, a gradual reduction of response to subsequent ketamine infusions was observed in the patient, who required more frequent infusions to obtain the same response. The authors emphasize that “the extension of ketamine's antidepressant effect with an increased dosage remains uncertain. … Ketamine has an addiction potential; thus, it is important to be mindful that increasing the ketamine dosage to address ketamine tachyphylaxis may enhance the potential for undesired consequences. Urgent studies investigating strategies to prolong ketamine's efficacy in adults with TRD are required.”

Finally, new prospects in depression treatment! Listen in as Dr. Jennifer Reid and Dr. Michael Thase discuss antidepressants, ketamine, psychedelics, and much more!Professor Thase is renowned as a teacher, mentor, administrator, researcher and clinician. One of the world's most highly cited psychiatrists, he has more than 1300 publications, as well as 18 books, including the award-winning Learning Cognitive Therapy, now in its second edition.Dr. Michael Thase is a Professor of Psychiatry in the Perelman School of Medicine of the University of Pennsylvania, and a member of the medical and research staff of the Corporal Michael J Crescenz Veterans Affairs Medical Center:Some questions Dr. Thase considers: 1)   You have been treating patients with depression for decades. How would you describe how your work has changed since you first started your career?2)   Looking back, do you think there were any missed opportunities when it comes to depression treatment?3)   How do you conceptualize difficult-to-treat depression, and is this something you discuss with patients? 4)   You're coauthor on a paper titled “The Neglected Role of Psychotherapy for Treatment-Resistant Depression.” What is its role?7)   What are your opinions about ketamine treatment in its various formulations: IV, sublingual, Esketamine?8)   What about psychedelics? Cannabis?9)   What are you hopeful about in the field of psychiatry?Thank you for checking out Our Reflective Minds. This post is public, so feel free to share it with anyone who may benefit from listening!A 1979 graduate of The Ohio State University College Medicine, Professor Thase completed internship, residency, chief residency, and post-doctoral training in clinical research at the University of Pittsburgh Medical Center (UPMC), where he rose to the rank of Professor of Psychiatry and was Chief of the Division of Academic Adult Psychiatry until 2007, when he moved to Philadelphia.  He is a Distinguished Life Fellow of the American Psychiatric Association, a Fellow of the American College of Neuropsychopharmacology and a member of the American College of Psychiatrists. He is a Past President of the American Society of Clinical Psychopharmacology, for which he was a member of their Board of Directors for more than two decades.  A Founding Fellow of the Academy of Cognitive Therapy, Professor Thase is a member of advisory boards for the Anxiety and Depressive Disorders Association, the National Network of Depression Centers, the Depression and Bipolar Support Alliance and the American Foundation for Suicide Prevention. In 2018 he was elected to the membership of Penn Medicine's Academy of Master Clinicians, an honor bestowed to only 2% of the medical school's faculty. Professor Thase's research has been continuously funded by various federal agencies for the past 37 years and currently focuses on novel therapies for difficult to treat depressive disorders and dissemination and implementation of cost-effective forms of cognitive behavior therapy.Jennifer Reid, MD on Instagram: @JenReidMDLooking for more from The Reflective Doc? Subscribe today so you don't miss out!Also check out Dr. Reid's regular contributions to Psychology Today: Think Like a ShrinkThanks for reading Our Reflective Minds! Subscribe for free to receive new posts and support my work.**********************Seeking a mental health provider? Try Psychology TodayNational Suicide Prevention Lifeline: 1-800-273-8255Dial 988 for mental health crisis supportSAMHSA's National Helpline - 1-800-662-HELP (4357)-a free, confidential, 24/7, 365-day-a-year treatment referral and information service (in English and Spanish) for individuals and families facing mental and/or substance use disorders.Disclaimer:The views expressed on this podcast reflect the host and guests, and are not associated with any organization or academic site. The information and other content provided on this podcast or in any linked materials, are not intended and should not be construed as medical advice, nor is the information a substitute for professional medical expertise or treatment. All content, including text, graphics, images and information, contained on or available through this website is for general information purposes only.If you or any other person has a medical concern, you should consult with your health care provider or seek other professional medical treatment. Never disregard professional medical advice or delay in seeking it because of something that have read on this website, blog or in any linked materials. If you think you may have a medical emergency, call your doctor or emergency services (911) immediately. You can also access the National Suicide Help Line at 1-800-273-8255 This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thereflectivemind.substack.com

This month, how animals hibernate and evidence that muscle myosin makes its own heat in the cold, brain scans to reveal how ketamine relieves resistant depression, the way the brain changes when animals build a bond, the evolution of flu outbreaks, and how aphantasia affects autobiographical memory. Get the references and the transcripts for this programme from the Naked Scientists website

Dr. Rosenbum discusses Interventional Psychiatry, the role of Stellate Ganglion Blocks in PTSD, Ketamine Infusions for Depression, and the role of Magnesium as a co-factor in ketamine infusions.  Other Announcements from NRAP Academy: PainExam App almost ready  Pain Management Board Prep migrated to NRAPpain.org AnesthesiaExam Board Prep migrated to NRAPpain.org PMRExam Board Prep migrated to NRAPpain.org   Live Workshop Calendar   Ultrasound Interventional Pain Course Registration      For Anesthesia Board Prep Click Here! References https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1293358/full   References   Górska N, Cubała WJ, Słupski J, Wiglusz MS, Gałuszko-Węgielnik M, Kawka M, Grzegorzewska A. Magnesium in Ketamine Administration in Treatment-Resistant Depression. Pharmaceuticals (Basel). 2021 May 3;14(5):430. doi: 10.3390/ph14050430. PMID: 34063604; PMCID: PMC8147622.   https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2021.513068/full   https://www.sutterhealth.org/services/behavioral-health/interventional-psychiatry   Hanling SR, Hickey A, Lesnik I, et al Stellate Ganglion Block for the Treatment of Posttraumatic Stress Disorder: A Randomized, Double-Blind, Controlled Trial Regional Anesthesia & Pain Medicine 2016;41:494-500.   https://www.psychiatrist.com/jcp/oral-ketamine-for-depression/  

Dr. Rosenbum discusses Interventional Psychiatry, the role of Stellate Ganglion Blocks in PTSD, Ketamine Infusions for Depression, and the role of Magnesium as a co-factor in ketamine infusions.  Other Announcements from NRAP Academy: PainExam App almost ready  Pain Management Board Prep migrated to NRAPpain.org AnesthesiaExam Board Prep migrated to NRAPpain.org PMRExam Board Prep migrated to NRAPpain.org   Live Workshop Calendar   Ultrasound Interventional Pain Course Registration      For Anesthesia Board Prep Click Here! References https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1293358/full   References   Górska N, Cubała WJ, Słupski J, Wiglusz MS, Gałuszko-Węgielnik M, Kawka M, Grzegorzewska A. Magnesium in Ketamine Administration in Treatment-Resistant Depression. Pharmaceuticals (Basel). 2021 May 3;14(5):430. doi: 10.3390/ph14050430. PMID: 34063604; PMCID: PMC8147622.   https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2021.513068/full   https://www.sutterhealth.org/services/behavioral-health/interventional-psychiatry   Hanling SR, Hickey A, Lesnik I, et al Stellate Ganglion Block for the Treatment of Posttraumatic Stress Disorder: A Randomized, Double-Blind, Controlled Trial Regional Anesthesia & Pain Medicine 2016;41:494-500.   https://www.psychiatrist.com/jcp/oral-ketamine-for-depression/  

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh welcomed Dr Hans Eriksson, chief medical officer at HMNC Brain Health, a precision psychiatry biopharma company, to discuss his work exploring current studies into the use of ketamine in mental health, HMNC Brain Health having last year announced topline results from a Phase 2 study looking at a take-at-home, oral ketamine option for Treatment Resistant Depression (or TRD).

What is ketamine used for? Could it be for me?Explore the world of ketamine therapy with Dr. Herman as she discusses common applications, addresses treatment-resistant depression, and offers strategies for optimizing therapy. Gain an understanding of the nuanced process of ketamine sessions, from detailed preparation to transformative integration, emphasizing trust, safety, and personal growth. In this episode we chat about:Dr. Sarah Herman's Journey into Psychedelic Healing (00:51)Ketamine for Treatment-Resistant Depression (08:04)Strategies for Optimal Ketamine Therapy (15:10)What is Ketamine Therapy Like? (21:45)A Holistic Approach to Ketamine Therapy (31:52)What to Look for in a Provider? (42:00)Episode Resources:Get help for Depression at Sofia Health | websiteBook holistic therapists at Sofia Health | book sessionBook Tai Chi, Qigong, meditation, mindfulness, and Yoga classes with Prime | get a free trialDr. Sara Herman on Instagram | InstagramDr. Sara Herman's website | websiteThank you so much for tuning in! If you enjoyed the content, we would love it if you took 2 minutes to leave a 5-star review!The Sofia Unfiltered Podcast by Sofia Health is for general informational and entertainment purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice. No doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have. For any health concerns, users should seek the assistance of their health care professionals.

If you're ready to kick depression to the curb but traditional treatments haven't worked for you, Shakti Therapy ((424) 336-0984) in Culver City offers holistic inpatient ketamine infusions that may be the guiding light you've been looking for. Go to https://www.shaktitherapyhealing.com/ketamine-therapy Shakti Therapy & Healing Services City: Culver City Address: 4236 Overland Ave Website https://www.shaktitherapyhealing.com/ Phone +1-424-336-0984 Email info@shaktitherapyhealing.com

Episode 159: Transcranial Magnetic Stimulation BasicsFuture Dr. Ameri explains how transcranial magnetic stimulation can be useful in the treatment of certain mental conditions.  Written by Omeed Ameri, MS-IV, Western University of Health Sciences, College of Osteopathic Medicine of the Pacific. Editing by Hector Arreaza, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Transcranial Magnetic Stimulation (TMS)TMS is a non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain to improve symptoms of depression and Obsessive-compulsive disorder (OCD). TMS uses the principles of electromagnetic inductions as described by Faraday's Law. When an electric current passes through the TMS coil, it creates a rapidly charging magnetic field, which passes unimpeded through the scalp and skull, inducing a secondary current in neural tissues of the brain, causing depolarization of neuronal membranes in targeted brain regions, mainly in the superficial layers of the cortex 1.5 to 2.5 cm beneath the coil.How it works.Depending on the frequency and pattern of magnetic pulses, TMS can either increase or decrease cortical excitability. High-frequency TMS (Generally > 1 Hz) is associated with increased cortical excitability and is often used for depression treatment. In contrast, low-frequency TMS (< 1 Hz) is typically used for anxiety and pain.This stimulation alters neurotransmitter release such as dopamine, serotonin, and norepinephrine. The repeated stimulation over sessions promotes synaptic plasticity, leading to more lasting changes in brain activity patterns associated with improved clinical outcomes. This is thought to have cascading effects throughout brain networks, and modulate dysfunctional circuits implicated in depression and restoring normal function. Effectiveness.The effectiveness of TMS can vary widely between individuals due to differences in anatomy, age, and specific conditions being treated. As such, ongoing research into how to personalize and optimize TMS parameters is ongoing. Research supporting the use of TMS in treatment-resistant depression.Research into the effectiveness of TMS and other therapy modalities targeting Treatment-Resistant Depression has been an ongoing effort for many years. In 2009, the American Academy of Family Physicians published Dr. Little's article titled “Treatment-Resistant Depression,” which noted that there was little evidence that TMS could significantly treat patients with treatment-resistant depression. Since that time, the American Journal of Psychiatry published a groundbreaking study in 2020, led by Dr. Cole, which explores the effectiveness of a novel treatment for treatment-resistant depression. This trial, known as Stanford Accelerated Intelligent Neuromodulation Therapy or SAINT, which demonstrates promising results in combating depression where traditional methods have failed. It was an open-label study that provides a new perspective on depression treatment, emphasizing rapid and targeted intervention. Twenty-two participants received 50 intermittent theta burst stimulation (iTBS), which is a more recent protocol for TMS treatment, over the course of five days. Each session included 1,800 pulses per session, with a 50-minute intersession interval, ten times a day. As a result of this intensive regimen, one participant withdrew from treatment, and 19 of the remaining 21 met remission criteria, with a score of less than 11 on the Montgomery-Asberg Depression Rating Scale. There were no serious adverse events reported, the participant who withdrew did so due to anxiety. Side effects included fatigue and some discomfort. 70% of participants continued to meet response criteria one-month post-treatment.TMS application for patients with OCD. Studies have shown promising results for the treatment of OCD with TMS. Typically, OCD is difficult to manage and requires the highest doses of SSRIs. In 2019, The American Journal of Psychiatry published Dr. Carmi's Article titled: “Efficacy and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective Multicenter Randomized Double-Blind Placebo-Controlled Trial”, which presents a comprehensive study on the effectiveness of dTMS in treating OCD. This multicenter, randomized, double-blind, placebo-controlled trial involved 99 OCD patients across 11 centers, who were treated with either high-frequency dTMS or sham dTMS, and focused on changes in the Yale-Brown Obsessive Compulsive Scale (YBOCS) scores.The treatment phase extended to 6 weeks with a total of 29 treatment sessions, following a 3-week screening phase and a 4-week follow-up phase. Patients were aged 22-68, with YBOCS scores greater than or equal to 20. At the start of the study, patients were already on a maintenance treatment with therapeutic dosages of SSRIs, or previously failed an SSRI and were currently being treated with Cognitive Behavioral Therapy. The results revealed that dTMS treatment participants showed a significantly greater reduction in YBOCS score compared to sham treatment (6.0 points vs. 3.3 points). The most frequent adverse effect was headaches. There was one incident of severe suicide ideation. On investigation, it was revealed that the suicide ideation preceded the treatment and required hospitalization for the patient. TMS therapy has shown promising results in treating both treatment-resistant depression and OCD. More research is required to assess the long-term viability of the treatment modality, and which treatment regimens have the greatest efficacy for various psychiatric disorders. I hope our listeners will keep TMS in mind when confronted with treatment-resistant depression and OCD.___________________Conclusion: Now we conclude episode number 159, “Transcranial Magnetic Stimulation,” also known as TMS. We learned from future Dr. Ameri that TMS has proven to be an effective option for treatment-resistant depression and Obsessive-compulsive disorder. When medications and therapy are not enough, you may consider this therapy for your patients. This week we thank Hector Arreaza and Omeed Ameri. Audio editing by Adrianne Silva.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:Cole, E., Stimpson, K. H., Bentzley, B. S., Gulser, M., Cherian, K., Tischler, C., Nejad, R., Pankow, H., Choi, E., Aaron, H., Espil, F. M., Pannu, J., Xiao, X., Duvio, D., Solvason, H. B., Hawkins, J., Guerra, A. T., Jo, B., Raj, K. S., . . .Williams, N. (2020). Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression. American Journal of Psychiatry, 177(8), 716–726. https://doi.org/10.1176/appi.ajp.2019.19070720Carmi, L., Tendler, A., Bystritsky, A., Hollander, E., Blumberger, D. M., Daskalakis, J., Ward, H. E., Lapidus, K., Goodman, W. K., Casuto, L., Feifel, D., Barnea‐Ygael, N., Roth, Y., Zangen, A., & Zohar, J. (2019). Efficacy and Safety of Deep transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A prospective multicenter randomized Double-Blind Placebo-Controlled Trial. American Journal of Psychiatry, 176(11), 931–938. https://doi.org/10.1176/appi.ajp.2019.18101180Little, A. (2009, July 15). Treatment-Resistant depression. AAFP. https://www.aafp.org/pubs/afp/issues/2009/0715/p167.htmlRoyalty-free music used for this episode: If You Were the One, downloaded on November 15, 2023, from https://www.videvo.net/ 

Though the stigma around mental illnesses has lessened, there is an ongoing mental health crisis affecting the country—and the rest of the world. In this episode of Medtech Talk, host Geoff Pardo speaks with Nolan Williams, M.D. Associate Professor of Psychiatry and Behavioral Sciences at Stanford University, about how electrical signaling abnormalities in the brain could be behind mental illnesses and the different options used to treat these ailments. Dr. Williams also delves into how his background in psychology and neurology helped him better understand patients in crisis, how Magnus Medical's methods differ from traditional transcranial magnetic stimulation therapy, and the difficult circumstance of the current state of hospitals and inpatient units. Medtech Talk Links:  Cambridge Healthtech Institute   Medtech Talk  Gilde Healthcare  Magnus Medical Links: Magnus Medical Stanford University Links: Stanford University School of Medicine Stanford University 

Our most prestigious guest to date joins Mariska and I for an exploration of transcranial magnetic stimulation and Esketamine for treatment resistant depression. I have been so curious about both of these forms of treatment so to get an expert on both was incredible! --- Send in a voice message: https://podcasters.spotify.com/pod/show/daniel-j-maigler/message

This week Kat is talking to the founders of Willows Health and Recovery, Selena Phillips & Rhonda Bartine. During this episode they discuss how Ketamine is now being used to help those who struggle with Treatment Resistant Depression. Follow Kat on Instagram: @Kat.Defatta Follow the podcast Instagram: @YouNeedTherapyPodcast Have a question, concern, guest idea, something else? Reach Kat at: Kathryn@youneedtherapypodcast.com Heard about Three Cords Therapy but don't know what it is? Click here!   Produced by: @HoustonTilleySee omnystudio.com/listener for privacy information.

Why is Ketamine being used to treat depression and anhedonia? In this science-y episode I'm going through the neuroscience of Ketamine and the brain, the chemical makeup of the drug, and why it's being used in many trials to treat people with treatment resistant depression and anhedonia. BRAIN FACT:ECT therapy – what is It, how does it work, what type of mental disorders is it used as a treatment for. Read more about ECT from the Mayo Clinic https://mayocl.in/3sfPN9W .  EXTRA READING Read Understanding Anhedonia https://bit.ly/anhedonia-explained . Mandal S, Sinha VK, Goyal N. Efficacy of ketamine therapy in the treatment of depression. Indian J Psychiatry. 2019 Sep-Oct;61(5):480-485. doi: 10.4103/psychiatry.IndianJPsychiatry_484_18. PMID: 31579184; PMCID: PMC6767816. LISTENER QUESTION:rr I'm doing my PHD and have realised I don't think I want a career in the thing I'm studying. After listening to your episode on the Sunk Cost Fallacy (https://bit.ly/46TyOJs ) I'm looking for advice on whether or not I should finish the PHD or not. LINKS: Send your Listener question to info@dyfmpod.com  Join DYFM + https://bit.ly/dyfm-membership . Subscribe to the DYFM 6 week course https://bit.ly/dyfm-course . Follow @dyfmpodcast on Instagram  Follow @alexispredez on Instagram   Join the DYFM Facebook Group https://bit.ly/dyfm-group . Follow @listnrentertainment on Instagram  CREDITS Host: Alexis Fernandez          Executive Producer & Editor: Elise CooperDigital Producer: Zoe Panaretos  DYFM Social Producer: Shania MaguaManaging Producer: Sam Cavanagh  Find more great podcasts like this at www.listnr.com/  See omnystudio.com/listener for privacy information.

Chronic stress can be at the root of everything from mental health struggles to digestive problems to heart disease.  Today on Raise the Line, we're going to learn about a wearable device made by Apollo Neuroscience that uses gentle vibrations to help the body adjust to stress. “Apollo is based on all the same principles that music is based on. It's wearable music for your body,” explains the company's co-founder and chief medical officer Dr. David Rabin, a neuroscientist, psychiatrist, health tech entrepreneur and inventor who has been studying the impact of chronic stress in humans for over fifteen years.  A close reading of non-Western medical practices led him to realize that, generally speaking, the focus was on reducing the “fight or flight” response and increasing our parasympathetic rest and recovery system. With that in mind, the Apollo device acts on the vagal nervous system with a gentle vibration that delivers safety signals to your skin in the form of low frequency music that you can't really hear, but you can feel. In this revealing conversation with host Shiv Gaglani, you'll learn more about how and why Apollo works and its connection to Rabin's interests in psychedelic-assisted therapy, the importance of safety in the provider-patient relationship, and how to effectively blend Western, Eastern and tribal approaches to medicine and healing. Mentioned in this episode: https://apolloneuro.com/

Didi Hairston is a mental health advocate who gives a compelling look into life being mentally ill while Black. Unfiltered, dark, and raw, she exposes the stigma and fear associated with mental illness in Black and Brown communities.  Didi's mental health advocacy organization is called Diva with Depression. Didi and her organization's mission is to break the chains of generational shame and trauma regarding mental illness in the Black and Brown communities, ending the passing down of toxic secrets and the stigma of mental illness. In this episode of Navigating Cancer Together, Didi discusses an important topic closely related to cancer - mental health. Despite not being a cancer patient, survivor, or caregiver, Didi sheds light on the mental health challenges faced by Black and Brown communities. This episode aims to raise awareness and promote understanding of the mental health struggles within these communities. Tune in to gain valuable insights and resources for supporting mental wellness during cancer and life's other journeys. ✨A few highlights from the show:  [00:01:32] Mental health in black communities. [00:06:01] Treatment-resistant depression [00:10:05] Strain on relationships. [00:13:03] Breaking the Mask of Depression. [00:16:35] Depression awareness resources. [00:23:34] Mental health and cancer. [00:26:01] Finding a support system. Resources:  Resources to Recover - https://www.rtor.org/bipoc-mental-health-equity-fact-sheet/  NAMI - https://www.nami.org/  NAMI Family-to-Family Support Group - https://www.nami.org/Support-Education/Mental-Health-Education/NAMI-Family-to-Family  Mental Health America - https://mhanational.org/  DSM5 Test - https://www.psychiatry.org/psychiatrists/practice/dsm/educational-resources/assessment-measures   

New Information About Fibromyalgia, Hypnosis as a Pain Management Tool , Over the Counter Birth Control and Ketamine for Treatment-Resistant Depression. See omnystudio.com/listener for privacy information.

This week our intrepid team of primary care physicians (Kate Rowland, Henry Barry, Gary Ferenchick and Mark Ebell) discuss treatment of resistant depression in older adults, recognizing and managing angry and disruptive patients, the best way to settle a cranky infant, and the AAFP 2022 Guideline on BP targets in adults with hypertension.

In this final story of season 4, Craig speaks with Wayne, a longtime patient of his who has battled treatment resistant depression and crippling anxiety for many years.  Wayne's story highlights a few crucial things— the fact that sometimes you can do everything right, do all the self-care things, yet still be waylaid by the crushing dark force of depression…this story also illustrates the power of the therapeutic relationship, and the fact that two people can deeply respect and care for each other, even when they land on opposite ends of the religious and political divide.BFTA on Instagram. @backfromtheabysspodcasthttps://www.instagram.com/backfromtheabysspodcast/BFTA/ Dr. Hhttps://www.craigheacockmd.com/podcast-page/

Not that long ago psychedelics were considered dangerous, and only enjoyed recreationally by a fringe element of society. Today, researchers are looking at drugs like psilocybin to develop treatments for depression, PTSD, addiction, and anxiety. This episode features guests steeped in the world of psychedelics who are finding new ways to treat mental health. Guests:Dr. Frank Wiegand, Chief Medical Officer, Beckley PsytechKurt Rasmussen, Ph.D., Chief Scientific Officer, Delix TherapeuticsClara Burtenshaw, Co-founder and Partner, Neo Kuma Ventures

Magic mushrooms are giving researchers hope in treating conditions like anxiety and depression, a new study may have found the key to increasing photosynthesis efficiency in plants, and research shows that we love being reached out to by old friends! Mushrooming Minds'They Broke My Mental Shackles': Could Magic Mushrooms be the Answer to Depression? by Josh Jacobshttps://www.theguardian.com/science/2019/jun/10/magic-mushrooms-treatment-depression-aztecs-psilocybin-mental-health-medicinePsilocybin Produces Substantial and Sustained Decreases in Depression and Anxiety in Patients with Life-Threatening Cancer: A Randomized Double-Blind Trial by Roland R. Griffiths, et al.https://dx.doi.org/10.1177%2F0269881116675513Rapid and Sustained Symptom Reduction Following Psilocybin Treatment for Anxiety and Depression in Patients with Life-Threatening Cancer: A Randomized Controlled Trial by Stephen Ross, et al.https://doi.org/10.1177/0269881116675512Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers by Rainer Kraehenmann, et al.https://doi.org/10.1016/j.biopsych.2014.04.010Therapeutic Mechanisms of Psilocybin: Changes in Amygdala and Prefrontal Functional Connectivity during Emotional Processing after Psilocybin for Treatment-Resistant Depression by Lea J. Mertens, et al.https://doi.org/10.1177%2F0269881119895520Limbic System: Amygdala by The University of Texas McGovern Medical Schoolhttps://nba.uth.tmc.edu/neuroscience/m/s4/chapter06.htmlSuper Plants Scientists Resurrect Ancient Enzymes To Improve Photosynthesis by Krishna Ramanujanhttps://cals.cornell.edu/news/2022/04/scientists-resurrect-ancient-enzymes-improve-photosynthesisImproving the Efficiency of Rubisco by Resurrecting Its Ancestors in the Family Solanaceae by Myat T. Lin, et al.https://doi.org/10.1126/sciadv.abm6871Scientists Take Step to Improve Crops' Photosynthesis, Yields by Krishna Ramanujanhttps://news.cornell.edu/stories/2021/08/scientists-take-step-improve-crops-photosynthesis-yieldsSmall Subunits Can Determine Enzyme Kinetics of Tobacco Rubisco Expressed in Escherichia Coli by Myat T. Lin, et al.https://doi.org/10.1038/s41477-020-00761-5Plz Call Your Friends“Unexpectedly reaching out to a friend is more appreciated than people assume, new study shows” by Douglas Heingartnerhttps://www.psychnewsdaily.com/reaching-out-more-appreciated-than-assumed/“The Surprise of Reaching Out: Appreciated More Than We Think” by Peggy J. Liu, SoYon Rim, Lauren Min, and Kate E. Minhttps://www.apa.org/pubs/journals/releases/psp-pspi0000402.pdfFollow Curiosity Daily on your favorite podcast app to get smarter with Calli and Nate — for free! Still curious? Get exclusive science shows, nature documentaries, and more real-life entertainment on discovery+! Go to https://discoveryplus.com/curiosity to start your 7-day free trial. discovery+ is currently only available for US subscribers.Find episode transcripts here: https://curiosity-daily-4e53644e.simplecast.com/episodes/mushrooming-minds-super-plants-plz-call-your-friends